4,4'-(tellurophene-2,5-diyl)dibenzimidamide

ID: ALA4878211

PubChem CID: 164627770

Max Phase: Preclinical

Molecular Formula: C18H16N4Te

Molecular Weight: 415.95

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  N=C(N)c1ccc(-c2ccc(-c3ccc(C(=N)N)cc3)[te]2)cc1

Standard InChI:  InChI=1S/C18H16N4Te/c19-17(20)13-5-1-11(2-6-13)15-9-10-16(23-15)12-3-7-14(8-4-12)18(21)22/h1-10H,(H3,19,20)(H3,21,22)

Standard InChI Key:  AGEGHRKLZZASRR-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 23 25  0  0  0  0  0  0  0  0999 V2000
   15.5233  -10.5437    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.5233  -11.3687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2391  -11.7812    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.8116  -11.7812    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8116  -12.6062    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0958  -13.0187    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0958  -11.3687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3799  -11.7812    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3799  -12.6062    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6682  -13.0187    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5792  -13.8368    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7732  -14.0093    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3607  -13.2934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5384  -13.2086    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0578  -13.8740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2355  -13.7892    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8979  -13.0347    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0798  -12.9499    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7819  -12.1787    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.5598  -13.5880    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.3868  -12.3692    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2050  -12.4541    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9137  -12.6811    0.0000 Te  0  0  0  0  0  2  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  4  7  2  0
  7  8  1  0
  8  9  2  0
  6  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 18 20  2  0
 17 21  1  0
 21 22  2  0
 14 22  1  0
 13 23  1  0
 10 23  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4878211

    ---

Associated Targets(Human)

HOXA9 DNA binding site (122 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 415.95Molecular Weight (Monoisotopic): 418.0437AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Depauw S, Lambert M, Jambon S, Paul A, Peixoto P, Nhili R, Marongiu L, Figeac M, Dassi C, Paul-Constant C, Billoré B, Kumar A, Farahat AA, Ismail MA, Mineva E, Sweat DP, Stephens CE, Boykin DW, Wilson WD, David-Cordonnier MH..  (2019)  Heterocyclic Diamidine DNA Ligands as HOXA9 Transcription Factor Inhibitors: Design, Molecular Evaluation, and Cellular Consequences in a HOXA9-Dependant Leukemia Cell Model.,  62  (3.0): [PMID:30645099] [10.1021/acs.jmedchem.8b01448]

Source